Acquisition by Brianne Jahn of 224005 shares of LianBio ADR subject to Rule 16b-3

LIANDelisted Stock  USD 2.18  0.05  2.24%   
About 61% of LianBio ADR's investor base is looking to short. The analysis of current outlook of investing in LianBio ADR suggests that many traders are alarmed regarding LianBio ADR's prospects. LianBio ADR's investing sentiment overview a quick insight into current market opportunities from investing in LianBio ADR. Many technical investors use LianBio ADR stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
Filed transaction by Lianbio officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at macroaxis.com
LianBio insider trading alert for grant of ordinary shares by Brianne Jahn, Chief Business Officer, on 31st of March 2023. This event was filed by Lianbio with SEC on 2023-03-31. Statement of changes in beneficial ownership - SEC Form 4

LianBio ADR Fundamental Analysis

We analyze LianBio ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LianBio ADR using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LianBio ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Book Value Per Share

Book Value Per Share Comparative Analysis

LianBio ADR is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.

LianBio ADR Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with LianBio ADR stock to make a market-neutral strategy. Peer analysis of LianBio ADR could also be used in its relative valuation, which is a method of valuing LianBio ADR by comparing valuation metrics with similar companies.

Peers

LianBio ADR Related Equities

VRCAVerrica Pharmaceuticals   6.25   
0%
100.0%
SNSESensei Biotherapeutics   3.92   
0%
62.0%
LRMRLarimar Therapeutics   2.77   
0%
44.0%
NXTCNextCure   2.60   
0%
41.0%
ABOSAcumen Pharmaceuticals   2.48   
0%
39.0%
DAWNDay One   1.13   
0%
18.0%
HOOKHookipa Pharma   0.52   
0%
8.0%
ASMBAssembly Biosciences   0.49   
0%
7.0%
ELDNEledon Pharmaceuticals   0.25   
4.0%
0%
ACHLAchilles Therapeutics   0.87   
13.0%
0%
NUVBNuvation Bio   1.18   
18.0%
0%
INZYInozyme Pharma   1.45   
23.0%
0%
TERNTerns Pharmaceuticals   1.56   
24.0%
0%
FENCFennec Pharmaceuticals   1.60   
25.0%
0%
TILInstil Bio   2.10   
33.0%
0%
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Consideration for investing in LianBio Stock

If you are still planning to invest in LianBio ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LianBio ADR's history and understand the potential risks before investing.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Commodity Directory
Find actively traded commodities issued by global exchanges
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios